Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Karch

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 12, 2015
Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET studyMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2009
Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PETClaudia Kuntner, Jens P Bankstahl, Marion Bankstahl, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humansMartin Brunner, Oliver Langer, Raute Sunder-Plassmann, et al.
Neurology|September 5, 2014
In vivo P-glycoprotein function before and after epilepsy surgeryMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain BarrierMartin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Epilepsia|May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamilOliver Langer, Martin Bauer, Alexander Hammers, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's diseaseMartin Bauer, Oliver Langer, Peter Dal-Bianco, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 12, 2015
Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET studyMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2009
Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PETClaudia Kuntner, Jens P Bankstahl, Marion Bankstahl, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humansMartin Brunner, Oliver Langer, Raute Sunder-Plassmann, et al.
Neurology|September 5, 2014
In vivo P-glycoprotein function before and after epilepsy surgeryMartin Bauer, Rudolf Karch, Markus Zeitlinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain BarrierMartin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Epilepsia|May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamilOliver Langer, Martin Bauer, Alexander Hammers, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's diseaseMartin Bauer, Oliver Langer, Peter Dal-Bianco, et al.
Pageof 5